National Institute of General Medical Sciences
OrganisationROR
Trials
Motor Imagery and Turning Practice to Improve Mobility: Pilot Trial
CollaboratorNo phaseNot yet recruiting202630 people15 Jul 2026clinicaltrials.gov
Training Induced Muscle-Adipose EV Communication
CollaboratorNo phaseNot yet recruiting202640 people6 Aug 2025clinicaltrials.gov
CollaboratorEarly phase 1Completed202110 people17 Nov 2020clinicaltrials.gov
CollaboratorPhase 4Terminated2016126 people2 Jul 2020clinicaltrials.gov
CollaboratorPhase 4Terminated201928 people15 Nov 2018clinicaltrials.gov
CollaboratorPhase 4Completed2016137 people8 Jun 2016clinicaltrials.gov
CollaboratorPhase 2/3Terminated201518 people22 May 2015clinicaltrials.gov
CollaboratorPhase 4Completed201370 people27 Mar 2015clinicaltrials.gov
CollaboratorPhase 2Status unknown201512 people9 Mar 2015clinicaltrials.gov
CollaboratorPhase 2Completed2013116 people6 Feb 2014clinicaltrials.gov
CollaboratorPhase 1Completed201121 people22 Dec 2011clinicaltrials.gov
CollaboratorPhase 1Completed201110 people4 Aug 2011clinicaltrials.gov
CollaboratorPhase 1Completed201111 people28 Jul 2011clinicaltrials.gov
CollaboratorPhase 4Completed2006682 people27 Nov 2008clinicaltrials.gov
CollaboratorPhase 2/3Terminated20041,126 people12 May 2008clinicaltrials.gov
CollaboratorPhase 2/3Completed2000644 people7 May 2008clinicaltrials.gov
CollaboratorPhase 1Completed200829 people22 Feb 2008clinicaltrials.gov
CollaboratorPhase 3Completed2007600 people26 Oct 2007clinicaltrials.gov
Awards made
R35Chemical Specific Measurements of Cellular Heterogeneity in OrganoidsR35GM1584232025–203010 Sept 2026reporter.nih.gov
R35Chemical Specific Measurements of Cellular Heterogeneity in OrganoidsR35GM158423US$416.7k2025–203010 Sept 2026reporter.nih.gov
R16Preservation of mitochondrial mass in a translational model of prolonged fasting and atrophy resistanceR16GM1657392026–20309 Sept 2026reporter.nih.gov
University of Alaska Fairbanks
R16Preservation of mitochondrial mass in a translational model of prolonged fasting and atrophy resistanceR16GM165739US$193.8k2026–20309 Sept 2026reporter.nih.gov
R35Regulation of Proteasome ActivityR35GM1452462022–20275 Sept 2026reporter.nih.gov
R35Regulation of Proteasome ActivityR35GM145246US$497.2k2022–20275 Sept 2026reporter.nih.gov
R35Folding, Misfolding, and Unfolding: How human 3D genome structure resists, adapts, or succumbs to physical stresses in health and diseaseR35GM1335572019–20293 Sept 2026reporter.nih.gov
University of Tennessee Knoxville
R35Folding, Misfolding, and Unfolding: How human 3D genome structure resists, adapts, or succumbs to physical stresses in health and diseaseR35GM133557US$50k2019–20293 Sept 2026reporter.nih.gov
R35Building biophysical and biochemical complexity in 3D cell and tissue constructsR35GM1474102022–20271 Sept 2026reporter.nih.gov
R35Building biophysical and biochemical complexity in 3D cell and tissue constructsR35GM147410US$373.5k2022–20271 Sept 2026reporter.nih.gov
P20Kansas Successful Aging and Resilience COBRE (K-SARC)P20GM1620022026–20311 Sept 2026reporter.nih.gov
P20Kansas Successful Aging and Resilience COBRE (K-SARC)P20GM1620022026–20311 Sept 2026reporter.nih.gov
University of Kansas Medical Center
P20Kansas Successful Aging and Resilience COBRE (K-SARC)P20GM162002US$2.6m2026–20311 Sept 2026reporter.nih.gov
R35A multiscale and multispecies approach for identifying shared mechanisms of limb and fin regenerationR35GM1614002026–20311 Sept 2026reporter.nih.gov
Louisiana State Univ A&m Col Baton Rouge
R35A multiscale and multispecies approach for identifying shared mechanisms of limb and fin regenerationR35GM161400US$375k2026–20311 Sept 2026reporter.nih.gov
R01Methods for Integrative Genomic Data AnalysisR01GM1297812018–202727 Aug 2026reporter.nih.gov
R01Methods for Integrative Genomic Data AnalysisR01GM129781US$452.6k2018–202727 Aug 2026reporter.nih.gov
R35Chromatin Landscape and DNA Repair Dynamics at Dysfunctional TelomeresR35GM1628432026–203127 Aug 2026reporter.nih.gov
University of Colorado, Denver
R35Chromatin Landscape and DNA Repair Dynamics at Dysfunctional TelomeresR35GM162843US$429k2026–203127 Aug 2026reporter.nih.gov
F32Role of the Long Non-Coding RNA TERRA in Regulating DNA Repair Pathways at TelomeresF32GM1671562026–202726 Aug 2026reporter.nih.gov
Funded papers
T32GM0073472 Oct 2026api.crossref.org
P20GM1131251 Oct 2026api.crossref.org
R01GM1538621 Oct 2026pubmed.ncbi.nlm.nih.gov
Proteostasis and ageing dissidence
R35GM1366601 Oct 2026api.crossref.org
GM1546381 Oct 2026api.crossref.org
R01GM02871930 Sept 2026pubmed.ncbi.nlm.nih.gov
Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age
R01GM124532, R35GM13342827 Sept 2026api.crossref.org
P20GM10343624 Sept 2026api.crossref.org
Age-associated Autoimmunity Driven by T cell Immunosenescence
R35GM15689322 Sept 2026pubmed.ncbi.nlm.nih.gov
P20GM104357, P30GM149404, U54GM11542819 Sept 2026api.crossref.org
U54GM104938, U54GM104942, U54GM133807, U54GM115516, U54GM115371, U54GM11545818 Sept 2026pubmed.ncbi.nlm.nih.gov
A transitional senescence program drives inflammatory monocyte state expansion in aging humans
R35GM15544713 Sept 2026api.crossref.org
Gero-Immunology: The critical role of aging when defining immune phenotypes
R35GM15709918 Aug 2026api.crossref.org